Abstract
IntroductionAcute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabine...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have